In a patient with chronic hepatitis B and a newly identified liver mass on imaging, which diagnosis is most likely?

Study for the Step 3 UWSA Exam with our challenging quiz. Prepare with detailed explanations for each question, ensuring you're well-equipped for success. Enhance your understanding and boost your exam confidence!

Multiple Choice

In a patient with chronic hepatitis B and a newly identified liver mass on imaging, which diagnosis is most likely?

Explanation:
Chronic hepatitis B markedly increases the risk of hepatocellular carcinoma because the virus can drive malignant transformation of hepatocytes, and HCC can develop even without cirrhosis. So a newly identified liver mass in someone with chronic HBV is most likely HCC. Hemangioma is a benign lesion with distinct imaging features and is less tied to HBV. Hepatoblastoma is a pediatric tumor, making it unlikely in adults. Metastatic disease would require a known primary elsewhere and is less favored than a primary HBV-related liver cancer in this setting.

Chronic hepatitis B markedly increases the risk of hepatocellular carcinoma because the virus can drive malignant transformation of hepatocytes, and HCC can develop even without cirrhosis. So a newly identified liver mass in someone with chronic HBV is most likely HCC. Hemangioma is a benign lesion with distinct imaging features and is less tied to HBV. Hepatoblastoma is a pediatric tumor, making it unlikely in adults. Metastatic disease would require a known primary elsewhere and is less favored than a primary HBV-related liver cancer in this setting.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy